Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) was the recipient of unusually large options trading activity on Friday. Traders bought 143,273 call options on the company. This is an increase of approximately 127% compared to the typical volume of 62,978 call options.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the company. Rothschild & Co Redburn started coverage on Core Scientific in a research report on Monday, September 21st. They issued a “neutral” rating and a $16.00 target price for the company. Wolfe Research reissued a “buy” rating on shares of Core Scientific in a research report on Wednesday, July 29th. Capital One Financial set a $33.00 price objective on Core Scientific in a research note on Thursday, July 30th. Needham & Company LLC reduced their price objective on Core Scientific from $35.00 to $28.00 and set a “buy” rating for the company in a research note on Friday. Finally, Freedom Capital upgraded Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Core Scientific currently has an average rating of “Moderate Buy” and an average target price of $30.54.
Get Our Latest Report on Core Scientific
More Core Scientific News
Here are the key news stories impacting Core Scientific this week:
- Positive Sentiment: Core Scientific reported Q3 2026 earnings of $0.47 per share, versus analysts’ expected loss, and revenue of $232.87 million, above estimates of about $196.5 million. Earnings also improved from a $0.46-per-share loss a year earlier. Zacks Q3 earnings article
- Neutral Sentiment: Needham cut its price target to $28 from $35 but kept a Buy rating. The reduced target is a cautionary signal, while the rating and stated upside from the quoted share price remain supportive. Needham analyst ratings
- Negative Sentiment: Insider Todd Duchene sold 10,000 shares for about $127,800, reducing his holdings by 0.88%. He still owned more than 1.1 million shares after the transaction, which may temper the significance of the sale. Insider sale report
Core Scientific Price Performance
CORZ traded up $0.57 on Friday, reaching $11.95. 22,239,665 shares of the company traded hands, compared to its average volume of 13,027,951. The company has a market cap of $3.84 billion, a price-to-earnings ratio of -2.68 and a beta of 5.56. The stock’s 50 day moving average price is $15.80 and its 200-day moving average price is $19.52. Core Scientific has a 52-week low of $10.59 and a 52-week high of $30.46.
Core Scientific (NASDAQ:CORZ – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.54. The company had revenue of $232.87 million during the quarter, compared to analysts’ expectations of $196.54 million. As a group, equities research analysts forecast that Core Scientific will post -1.36 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the business’s stock in a transaction on Monday, October 19th. The shares were sold at an average price of $13.87, for a total transaction of $138,700.00. Following the sale, the insider directly owned 1,143,286 shares of the company’s stock, valued at $15,857,376.82. The trade was a 0.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last 90 days, insiders have purchased 19,000 shares of company stock worth $342,290 and have sold 100,000 shares worth $1,628,600. Insiders own 1.70% of the company’s stock.
Hedge Funds Weigh In On Core Scientific
A number of hedge funds have recently modified their holdings of the stock. Parallel Advisors LLC boosted its position in Core Scientific by 125.0% during the third quarter. Parallel Advisors LLC now owns 1,800 shares of the company’s stock valued at $29,000 after purchasing an additional 1,000 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in Core Scientific by 1,371.3% in the second quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock valued at $30,000 after purchasing an additional 1,097 shares in the last quarter. CoreCap Advisors LLC acquired a new position in Core Scientific in the 2nd quarter worth about $36,000. Mirae Asset Global Investments Co. Ltd. acquired a new position in Core Scientific in the 3rd quarter worth about $42,000. Finally, Rakuten Securities Inc. purchased a new stake in shares of Core Scientific during the 2nd quarter worth about $47,000.
Core Scientific Company Profile
Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.
Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.
See Also
- Five stocks we like better than Core Scientific
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
